ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Regulatory news

EU · CHMP positive opinion

Daraxonrasib (Rasonque)

Treatment of adult patients with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy.

Orphan
CHMP opinion 15 Oct 2026 · Revolution Medicines Netherlands B.V.

Research

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.